Cargando…
Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines
RNA interference (RNAi) is a process in which double-stranded RNA induces the post-transcriptional sequence-specific degradation of homologous messenger RNA. The present study was carried out to apply the RNAi technology to inhibit the replication of feline immunodeficiency virus (FIV). Four small i...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117143/ https://www.ncbi.nlm.nih.gov/pubmed/17125939 http://dx.doi.org/10.1016/j.vetmic.2006.10.033 |
_version_ | 1783514304529563648 |
---|---|
author | Baba, Kenji Mizukoshi, Fuminori Goto-Koshino, Yuko Setoguchi-Mukai, Asuka Fujino, Yasuhito Ohno, Koichi Tsujimoto, Hajime |
author_facet | Baba, Kenji Mizukoshi, Fuminori Goto-Koshino, Yuko Setoguchi-Mukai, Asuka Fujino, Yasuhito Ohno, Koichi Tsujimoto, Hajime |
author_sort | Baba, Kenji |
collection | PubMed |
description | RNA interference (RNAi) is a process in which double-stranded RNA induces the post-transcriptional sequence-specific degradation of homologous messenger RNA. The present study was carried out to apply the RNAi technology to inhibit the replication of feline immunodeficiency virus (FIV). Four small interfering RNAs (siRNAs) homologous to the FIV gag gene were synthesized and transfected into a feline fibroblastic cell line chronically infected with FIV (CRFK/FIV). These synthetic siRNAs efficiently inhibited the replication of FIV. Next, we examined the effect of retroviral vector-mediated transfer of FIV-specific short hairpin RNA (shRNA) on the replication of FIV in a feline T-cell line chronically infected with FIV (FL4). The retroviral vector-mediated transfer of FIV-specific shRNA was shown to markedly inhibit the replication of FIV in the FL4 cells. These results provide useful information for the development of RNAi-based gene therapy strategy to control FIV infection. |
format | Online Article Text |
id | pubmed-7117143 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71171432020-04-02 Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines Baba, Kenji Mizukoshi, Fuminori Goto-Koshino, Yuko Setoguchi-Mukai, Asuka Fujino, Yasuhito Ohno, Koichi Tsujimoto, Hajime Vet Microbiol Article RNA interference (RNAi) is a process in which double-stranded RNA induces the post-transcriptional sequence-specific degradation of homologous messenger RNA. The present study was carried out to apply the RNAi technology to inhibit the replication of feline immunodeficiency virus (FIV). Four small interfering RNAs (siRNAs) homologous to the FIV gag gene were synthesized and transfected into a feline fibroblastic cell line chronically infected with FIV (CRFK/FIV). These synthetic siRNAs efficiently inhibited the replication of FIV. Next, we examined the effect of retroviral vector-mediated transfer of FIV-specific short hairpin RNA (shRNA) on the replication of FIV in a feline T-cell line chronically infected with FIV (FL4). The retroviral vector-mediated transfer of FIV-specific shRNA was shown to markedly inhibit the replication of FIV in the FL4 cells. These results provide useful information for the development of RNAi-based gene therapy strategy to control FIV infection. Elsevier B.V. 2007-03-10 2006-11-27 /pmc/articles/PMC7117143/ /pubmed/17125939 http://dx.doi.org/10.1016/j.vetmic.2006.10.033 Text en Copyright © 2006 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Baba, Kenji Mizukoshi, Fuminori Goto-Koshino, Yuko Setoguchi-Mukai, Asuka Fujino, Yasuhito Ohno, Koichi Tsujimoto, Hajime Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines |
title | Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines |
title_full | Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines |
title_fullStr | Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines |
title_full_unstemmed | Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines |
title_short | Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines |
title_sort | application of rna interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117143/ https://www.ncbi.nlm.nih.gov/pubmed/17125939 http://dx.doi.org/10.1016/j.vetmic.2006.10.033 |
work_keys_str_mv | AT babakenji applicationofrnainterferenceforinhibitingthereplicationoffelineimmunodeficiencyvirusinchronicallyinfectedcelllines AT mizukoshifuminori applicationofrnainterferenceforinhibitingthereplicationoffelineimmunodeficiencyvirusinchronicallyinfectedcelllines AT gotokoshinoyuko applicationofrnainterferenceforinhibitingthereplicationoffelineimmunodeficiencyvirusinchronicallyinfectedcelllines AT setoguchimukaiasuka applicationofrnainterferenceforinhibitingthereplicationoffelineimmunodeficiencyvirusinchronicallyinfectedcelllines AT fujinoyasuhito applicationofrnainterferenceforinhibitingthereplicationoffelineimmunodeficiencyvirusinchronicallyinfectedcelllines AT ohnokoichi applicationofrnainterferenceforinhibitingthereplicationoffelineimmunodeficiencyvirusinchronicallyinfectedcelllines AT tsujimotohajime applicationofrnainterferenceforinhibitingthereplicationoffelineimmunodeficiencyvirusinchronicallyinfectedcelllines |